Treatment utilization for endometriosis symptoms: a cross-sectional survey study of lifetime experience
article
OA: closed
CC0
⤵ 80 in-corpus citations
AI-generated summary
This cross-sectional survey examined lifetime treatment utilization for endometriosis symptoms, reporting on the types of treatments sought and their perceived effectiveness.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
ObjectiveTo examine the lifetime utilization and perceived benefit of medical treatments and surgical procedures for endometriosis-related symptoms.DesignCross-sectional study of self-reported survey data.SettingAcademic research setting.Patient(s)Self-reported surgically diagnosed endometriosis by 1,160 women responding to the 1998 Endometriosis Association survey.Intervention(s)None.Main outcome measure(s)Use, perceived helpfulness, and outcomes of medical treatments and surgical procedures.Result(s)Ninety-five percent of respondents reported pelvic pain, had endured symptoms on average of 16 years, and were young (mean: 36 years), white, and educated. Many women (46%) had tried three or more medical treatments, and almost 20% took them for 10+ years. Many reported medical treatments as helpful for symptoms (range, 36.4%-61.9%), but some reported stopping because of ineffectiveness (range, 15.6%-26.1%) or side effects (range, 10.0%-43.5%). Danazol or medroxyprogesterone acetate (MPA) was most commonly stopped because of side effects (range, 40.7%-43.5%). Surgical procedures were performed at least three times on 42%. Nearly 20% had a hysterectomy or oophorectomy; these procedures were reported as most successful in improving symptoms (45.9% and 37.8%, respectively).Conclusion(s)Despite reporting various treatments as helpful, women used many different types and endured symptoms for an average of almost two decades, indicating the profound effect of endometriosis on women's health.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (24)
- Chiropractic care for women with chronic pelvic pain: a prospective single-group intervention study. via openalex
- Endometriosis : contemporary concepts in clinical management via openalex
- Follow-up report on a randomized controlled trial of laser laparoscopy in the treatment of pelvic pain associated with minimal to moderate endometriosis via openalex
- High rates of autoimmune and endocrine disorders, fibromyalgia, chronic fatigue syndrome and atopic diseases among women with endometriosis: a survey analysis via openalex
- Laparoscopic excision of endometriosis: A randomized, placebo-controlled trial via openalex
- Randomized controlled trial of depot leuprolide in patients with chronic pelvic pain and clinically suspected endometriosis via openalex
- Randomized Controlled Trial of Depot Leuprolide in Patients With Chronic Pelvic Pain and Clinically Suspected Endometriosis via openalex
- W2007161114 via openalex
- W2106508366 via openalex
- W2146129917 via openalex
- W2440932938 via openalex
- W4285719527 via openalex
- W6603919614 via openalex
- W6608061062 via openalex
- W6642328737 via openalex
- W6681413492 via openalex
- W97865756 via openalex
- W6718803013 via openalex
- W100949555 via openalex
- doi:10.1097/01.aog.0000135275.63494.3d via openalex
- W1969272687 via openalex
- W1972603088 via openalex
- W1984802892 via openalex
- W2003711731 via openalex
Cited by (50)
- Endovaginal Medical Ozone Treatment as an Adjuvant in Endometriosis: A Double-Blind Randomized Controlled Trial 2026
- The needs, preferences, and priorities for supportive healthcare in people living with endometriosis: A qualitative exploratory study 2026
- Strategies for self-management of endometriosis symptoms: An observational study 2025
- 'In the weeds': navigating the complex concerns, challenges and choices associated with medicinal cannabis consumption for endometriosis 2025
- Patients' knowledge, attitudes, and practices concerning endometriosis and its long-term management 2025
- Exercise may benefit those with endometriosis: the Exercise 4 Endo trans-Tasman online survey 2024
- Nutrition Interventions in the Treatment of Endometriosis: A Scoping Review 2024
- Treatment of moderate-severe pain associated with early stage endometriosis; a consensus panel summary 2024
- “I wish I didn’t have to defend myself for not being in pain all the time”: Healthcare Interactions between People with Endometriosis and General Practitioners about Therapeutic Cannabis Use: A Narrative Analysis 2024
- A survey of cost, access and outcomes for cannabinoid-based medicinal product use by Australians with endometriosis 2024
- Investigational drugs for the treatment of dysmenorrhea 2024
- Nutrition in the prevention and treatment of endometriosis: A review 2023
- Cannabis and Endometriosis: The Roles of the Gut Microbiota and the Endocannabinoid System 2023
- Cannabis for endometriosis-related pain and symptoms: It's high time that we see this as a legitimate treatment 2023
- Cannabis and Endometriosis: The Roles of the Gut Microbiota and the Endocannabinoid System 2023
- Cannabis and Endometriosis: The roles of the gut microbiota and the<br aria-hidden="true" />endocannabinoid system 2023
- Nutrition in the prevention and management of endometriosis symptoms - a current literature review 2023
- Treatment of moderate-severe pain associated with early stage endometriosis; a consensus panel summary 2023
- Endometriosis: Features and potential role of medicinal cannabis 2023
- The Place of Cannabinoids in the Treatment of Gynecological Pain 2023
- Current endometriosis care and opportunities for improvement 2023
- Medical Prevention of Miscarriage in Women with Ovarian Endometriosis in Reproductive Age 2022
- Az endometriózis pszichológiai támogatása 2022
- The experiences of endometriosis patients with diagnosis and treatment in New Zealand 2022
- Evaluation of the Effect of a Combined Gestodene Containing Oral Contraceptive on the Mechanisms of Proliferative Regulation in External Genital Endometriosis 2022
- Psychological treatment of endometriosis and support in coping withthe disease 2022
- Manual Acupuncture Plus Usual Care Versus Usual Care Alone in the Treatment of Endometriosis-Related Chronic Pelvic Pain: A Randomized Controlled Feasibility Study 2021
- A cross-sectional study of traditional Chinese medicine practitioner’s knowledge, treatment strategies and integration of practice of chronic pelvic pain in women 2021
- Additional file 1 of The effectiveness of a modified Gui Zhi Fu Ling Wan formulation (Gynoclear™) for the treatment of endometriosis: a study protocol for a placebo-controlled, double-blind, randomised controlled trial 2021
- Efficacy of dienogest vs combined oral contraceptive on pain associated with endometriosis: Randomized clinical trial 2021
- Treatment use and satisfaction in Australian women with endometriosis: a mixed‐methods study 2021
- Yoga, cognitive–behavioural therapy versus education to improve quality of life and reduce healthcare costs in people with endometriosis: a randomised controlled trial 2021
- The effectiveness of a modified Gui Zhi Fu Ling Wan formulation (Gynoclear™) for the treatment of endometriosis: a study protocol for a placebo-controlled, double-blind, randomised controlled trial 2021
- Effect of hysterectomy on pain in women with endometriosis: a population‐based registry study 2020
- The Link between Environmental Toxicant Exposure and Endometriosis Re-Examined 2020
- The effect of self-care counseling on depression and anxiety in women with Endometriosis: a randomized controlled trial. 2020
- The Effectiveness of a Modified Gui Zhi Fu Ling Wan Formulation (Gynoclear™) for The Treatment of Endometriosis: A Study Protocol for a Placebo Controlled, Double Blind, Randomised Controlled Trial. 2020
- Safety and Effectiveness of Dienogest (Visanne®) for Treatment of Endometriosis: A Large Prospective Cohort Study 2020
- Effect of self-care counselling on depression and anxiety in women with endometriosis: a randomized controlled trial 2020
- Cannabis Use, a Self-Management Strategy Among Australian Women With Endometriosis: Results From a National Online Survey 2019
- The cost of illness and economic burden of endometriosis and chronic pelvic pain in Australia: A national online survey 2019
- Self-management strategies amongst Australian women with endometriosis: a national online survey 2019
- <p>Rethinking endometriosis care: applying the chronic care model via a multidisciplinary program for the care of women with endometriosis</p> 2019
- Endometriosis as a Comorbid Condition in Chronic Fatigue Syndrome (CFS): Secondary Analysis of Data From a CFS Case-Control Study 2019
- Early life abuse and risk of endometriosis 2018
- Efficacy of acupuncture on pelvic pain in patients with endometriosis: study protocol for a randomized, single-blind, multi-center, placebo-controlled trial 2018
- The Usefulness of CD34, PCNA Immunoreactivity, and Histopathological Findings for Prediction of Pain Persistence After the Removal of Endometrioma 2018
- A need for a better understanding of the role, value and effectiveness of complementary and integrative medicine for women with endometriosis 2017
- Manual acupuncture plus usual care versus usual care alone in the treatment of endometriosis-related chronic pelvic pain: study protocol for a randomised controlled feasibility study 2017
- Reevaluating response and failure of medical treatment of endometriosis: a systematic review 2017
Source provenance
- europepmc
- last seen: 2026-10-01T06:15:55.914501+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:15:06.633332+00:00
- unpaywall
- last seen: 2026-08-12T06:43:03.944938+00:00
License: CC0
· commercial use OK